Hans Gille

Dr. Hans Gille

orcid

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2006 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
NHNicholas Hearle
Nicholas Hearle
VSValérIe Schumacher
ValérIe Schumacher
FMFred H. Menko
Fred H. Menko
SOSylviane Olschwang
Sylviane Olschwang
LBLisa A. Boardman
Lisa A. Boardman
Richard HoulstonRichard Houlston
Richard Houlston
Background: Although an increased cancer risk in Peutz-Jeghers syndrome is established, data on the spectrum of tumors associated with the disease and the influence of germ-line STK11/LKB1 (serine/threonine kinase) mutation status are limited. Experimental Design: We analyzed the incidence of cancer in 419 individuals with Peutz-Jeghers syndrome, and 297 had documented STK11/LKB1 mutations. Results: Ninety-six cancers were found among individuals with Peutz-Jeghers syndrome. The risk for developing cancer at ages 20, 30, 40, 50, 60, and 70 years was 2%, 5%, 17%, 31%, 60%, and 85%, respectively. The most common cancers represented in this analysis were gastrointestinal in origin, gastroesophageal, small bowel, colorectal, and pancreatic, and the risk for these cancers at ages 30, 40, 50, and 60 years was 1%, 9%, 15%, and 33%, respectively. In women with Peutz-Jeghers syndrome, the risk of breast cancer was substantially increased, being 8% and 31% at ages 40 and 60 years, respectively. Kaplan-Meier analysis showed that cancer risks were similar in Peutz-Jeghers syndrome patients with identified STK11/LKB1 mutations and those with no detectable mutation (log-rank test of difference χ2 = 0.62; 1 df; P = 0.43). Furthermore, the type or site of STK11/LKB1 mutation did not significantly influence cancer risk. Conclusions: The results from our study provide quantitative information on the spectrum of cancers and risks of specific cancer types associated with Peutz-Jeghers syndrome.

19 October 2001 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
Jurgen PiekJurgen Piek
Jurgen Piek
PDPaul J. van Diest
Paul J. van Diest
RZRonald P. Zweemer
Ronald P. Zweemer
JJJan W. Jansen
Jan W. Jansen
RPRia J. J. Poort‐Keesom
Ria J. J. Poort‐Keesom
RVRené H. M. Verheijen
René H. M. Verheijen

1 March 1986 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
TSTh. M. Starink
Th. M. Starink
JVJ. P. W. van der Veen
J. P. W. van der Veen
FAF. Arwert
F. Arwert
LWL. P. de Waal
L. P. de Waal
GLG. G.DE Lange
G. G.DE Lange
AEA. W. Eriksson
A. W. Eriksson

1 November 1996 in Nature Genetics
Verified
Journal Article
Closed access
JFJerome R. Lo Ten Foe
Jerome R. Lo Ten Foe
MRMartin A. Rooimans
Martin A. Rooimans
LBLucine Bosnoyan-Collins
Lucine Bosnoyan-Collins
NANoa Alon
Noa Alon
MWMario Wijker
Mario Wijker
HJHans Joenje
Hans Joenje

1 January 2011 in The Lancet Oncology
Verified
Journal Article
Closed access
MKMarlies Je Kempers
Marlies Je Kempers
RKRoland P Kuiper
Roland P Kuiper
COCharlotte W Ockeloen
Charlotte W Ockeloen
PCPierre O Chappuis
Pierre O Chappuis
PHPierre Hutter
Pierre Hutter
MLMarjolijn Jl Ligtenberg
Marjolijn Jl Ligtenberg

1 June 2004 in Gastroenterology
Verified
Journal Article
Closed access
WLWendy Lim
Wendy Lim
SOSylviane Olschwang
Sylviane Olschwang
JKJosbert J Keller
Josbert J Keller
AWAnne Marie Westerman
Anne Marie Westerman
FMFred H Menko
Fred H Menko
RHRichard S Houlston
Richard S Houlston